Genzyme rejects Sanofi offer

Monday 30 August 2010

Genzyme Corp has rejected an unsolicited cash takeover bid from Sanofi-Aventis which values the company at $69 per share or $18.5 billion. The rejection was communicated in a letter to the Sanofi CEO Christopher Viehbacher.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United States